Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
63 Cards in this Set
- Front
- Back
a. Where are chylomicrons formed?
|
i. Intestinal epithelial cells
ii. Assembled in Golgi apparatus |
|
b. Where are nascent chylomicrons secreted?
|
i. Into lymph
ii. apoA proteins iii. apoB-48 |
|
c. What do chylomicrons accumulate in the blood stream?
|
i. apoC and apoE from HDL
|
|
d. What is LPL’s effect on chylomicrons?
|
i. Removes TAG-- chylomicrons become smaller
|
|
e. How are phospholipids transferred to HDL?
|
i. PLTP
|
|
f. What components of chylomicrons are transferred to HDL?
|
i. Surface molecules→
1. Phospholipid 2. Cholesterol 3. apoA and apoC |
|
g. After losing its surface components, what do chylomicrons gain from HDL?
|
i. More apoE
ii. Cholesteryl ester |
|
h. What clears chylomicron remnants from blood?
|
i. LDL binds apoE
ii. LRP iii. Both in liver |
|
i. When are chylomicrons present in the blood?
|
i. After a meal
ii. ½ life is less than 1 hours |
|
j. What is the distribution of chylomicrons to the body tissues?
|
i. 80% to heart, adipose and muscle
ii. 20% to liver |
|
a. Where are VLDL and LDL synthesized?
|
i. Liver
|
|
b. What are the steps of VLDL and LDL synthesis?
|
i. Lipids assembled in ER
ii. Apoproteins synthesized in RER iii. VLDL assembled in Golgi iv. Secreted into bloodstream as nascent VLDL |
|
c. What does VLDL acquire from HDL in the bloodstream?
|
i. apoC
ii. apoE |
|
d. What removes TAGs from VLDL?
|
i. LPL
|
|
e. What causes VLDL to become smaller?
|
i. apoC, phospholipids, and TAGs transferred to HDL
|
|
f. What do VLDL remnants acquire in the bloodstream?
|
i. Choelsteryl ester
|
|
g. How is VLDL/IDL removed from the bloodstream?
|
i. LDL (B100/E) receptor in liver
ii. 50% of IDL cleared by liver |
|
h. What happens to the 50% of IDL not cleared by the liver?
|
i. It is converted to LDL
ii. Becomes anchored to HL→ removal of TAG and phospholipids iii. ApoE is transferred to HDL |
|
i. How many molecules of apoB100 does LDL contain?
|
i. 1
|
|
j. What is the half-life of plasma LDL?
|
i. Up to several days
|
|
k. How is LDL cleared from the blood?
|
i. LDL receptor
ii. LRP receptor iii. In liver (70%) |
|
l. What clears the 30% of LDL not cleared by the liver?
|
i. Adrenal and gonads-- LDL scavenges cholesterol for steroid hormones
ii. Macrophages |
|
a. Where is HDL synthesized?
|
i. Liver and intestine
|
|
b. What are the characteristics of nascent HDL?
|
i. Disc-shaped
ii. Phospholipid rich |
|
c. What are the apoproteins of nascent HDL from the liver?
|
i. AI
ii. AII iii. apoE iv. apoC |
|
d. What are the apoproteins of nascent HDL from the intestine?
|
i. AI
|
|
e. What does HDL acquire in the bloodstream?
|
i. Cholesterol from outer leaflet of cells by ABCA1
ii. LCAT from plasma iii. CETP from plasma iv. Other apoproteins/lipoproteins |
|
f. How does HDL dock to other cells?
|
i. apoAI
ii. apoE |
|
g. How is HDL involved in reverse cholesterol transport?
|
i. HDL3 expresses a high LCAT activity
ii. LCAT removes cholesterol, converting it to cholesteryl ester iii. HDL3 transfers CE to IDL and chylomicron remnants in exchange for phospholipid and TAGs |
|
h. How does HDL3 become HDL2?
|
i. Acquiring more phospholipids and increasing in size through reverse cholesterol transport
|
|
i. For what is HDL2 a substrate?
|
i. HL→ hydrolyzes excess TAG and PL
|
|
j. How do SRB1 and HDL2 interact? What is the result of this interaction?
|
i. SRB1 of liver binds HDL2 and selectively transfers CE to liver cell
ii. HDL3 is regenerated from HDL2 in this manner |
|
a. What causes abetalipoproteinemia?
|
i. Deficiency of a TAG transfer protein in ER
ii. Liver and intestine unable to assemble or secrete apoB-containing lipoproteins |
|
b. What is absent in abetalipoproteinemia?
|
i. Chylomicrons
ii. VLDL iii. LDL |
|
c. What are the consequences of abetalipoproteinemia?
|
i. Severe fat malabsorption
ii. Accumulation of TAGs in intestine and liver iii. Deficiencies of fat soluble vitamins |
|
d. What will untreated patients of abetalipoproteinemia develop?
|
i. Ataxia
ii. Retinitis pigmentosa iii. Myopathy |
|
a. How do you tx abetalipoproteinemia?
|
i. Vitamin E
|
|
f. What causes Tangier disease?
|
i. Deficiency of ABCA1
|
|
g. What are the consequences of Tangier disease?
|
i. HDL cannot be formed
ii. Decreased LDL iii. Cholesteryl ester deposits in RES, bone marrow, and Schwann cells |
|
h. What are the symptoms of Tangier disease?
|
i. Peripheral neuropathy
ii. Hepatosplenomegaly iii. LAD iv. Mild tendency for early atherosclerosis |
|
i. What is the cause of familial hypercholesterolemia?
|
i. Deficiency of LDL receptor
|
|
j. What is the average cholesterol level in familial hypercholesterolemia?
|
i. 350 mg/dL
|
|
k. What form of inheritance is more common in familial hypercholesterolemia?
|
i. Heterozygotes→ more severe form of disease
|
|
l. What are the consequences of familial hypercholesterolemia?
|
i. Accelerated CHD
ii. Homozygotes die by age of 20 |
|
m. What causes xanthomas?
|
i. Mutations in LDL receptor
|
|
n. What are the consequences of familial LCAT deficiency?
|
i. Block in reverse cholesterol transport
ii. Limited ability of HDL to acquire cholesterol from VLDL or chylomcirons iii. Elevated blood cholesterol and TAGs |
|
o. What are the symptoms of familial LCAT deficiency?
|
i. Free cholesterol accumulates in most tissues
ii. Kidney disease iii. Corneal clouding iv. Mild tendency for early atherosclerosis |
|
p. What are the consequences of a CETP deficiency?
|
i. Benign
ii. Cholesteryl esters cannot be transferred from HDL to other lipoproteins iii. Homozygotes have 4x elevation of HDL cholesterol iv. LDL is normal or low |
|
q. How is reverse cholesterol transport still possible in someone with a CETP deficiency?
|
i. SRB1 receptors of liver
ii. Endocytosis of HDL with multiple copies of apoE |
|
a. What is the plasma lipid profile of type I hyperchylomicronemia?
|
a. Greatly increased TAGs
b. Cholesterol slightly elevated c. Not associated with increased atherosclerosis |
|
b. What causes type I hyperlipoproteinemia?
|
a. LPL deficiency
b. apoC-II deficiency |
|
c. What are the symptoms of type I hyperlipoproteinemia?
|
a. Eruptive xanthomas
b. Abdominal pain after a fat-containing meal c. Recurrent pancreatitis |
|
d. What is the manifestation of type II hypercholesterolemia?
|
a. LDL elevation
b. Atherosclerosis is a major risk |
|
e. What causes type II hypercholesterolemia?
|
a. Familial hypercholesterolemia
b. Obesity, diabetes (less common) |
|
f. What is the plasma lipid profile of type III dysbetalipoproteinemia?
|
a. Increased TAGs
b. Increased cholesterol |
|
g. What causes type III dysbetalipoproteinemia?
|
a. Homozygotes for apoE2
b. ApoE2 does not bind hepatic apoE receptors c. Chylomicrons and VLDL remnants accumulate |
|
h. What are the symptoms of dysbetalipoproteinemia?
|
a. Xanthomas
b. Increased risk of CHD |
|
i. How do you tx dysbetalipoproteinemia?
|
a. Dietary changes
|
|
a. What is the plasma lipid profile of type IV/hypertriglyceridemia?
|
a. Increased TAGs
b. Hypercholesterolemia due to cholesterol content of VLDL |
|
k. What causes type IV/hypertriglyceridemia?
|
a. Obesity
b. Type II diabetes c. Progesterone-rich contraceptives d. Excess dietary carbohydrates |
|
l. What is the plasma lipid profile of type V/hyperlipoproteinemias?
|
a. Increased TAGs
b. Increased cholesterol |
|
m. What is the cause of type V/hyperlipoproteinemias?
|
a. Increased chylomicrons and VLDL
b. Associated with uncontrolled diabetes, obesity, and kidney disease |
|
n. How do you tx type V/hyperlipoproteinemias?
|
a. Dietary changes
|